NCT04768062 Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04740554 Heart Rate Variability in Individuals With Duchenne Muscular Dystrophy Status COMPLETED Phase N/A
NCT04708314 An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy Status TERMINATED Phase PHASE4
NCT04687020 Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502) Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04632940 Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD Status TERMINATED Phase PHASE3
NCT04607824 Heart Rate Variability in Duchenne Muscular Dystrophy During Computer Task Status COMPLETED Phase N/A
NCT04587908 A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy(REACH-DMD) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04529707 Sleep Intervention in Young Boys with Duchenne Muscular Dystrophy Status COMPLETED Phase NA
NCT04433234 Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04371666 Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD) Status TERMINATED Phase PHASE3
NCT04335942 Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor Status COMPLETED Phase NA
NCT04287582 The Evaluation of Muscle Activation in Climbing up Stairs Activity in Children With Duchenne Muscular Dystrophy Status UNKNOWN Phase N/A
NCT04281485 Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04240314 AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications. Status COMPLETED Phase PHASE1/PHASE2
NCT04179409 A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subjects With DuchenneMuscular Dystrophy Carrying Eligible DMD Duplications. Status COMPLETED Phase PHASE2